awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49886531-59468A00-054C-4A76-B187-887F2BF9542D
Q49886531-59468A00-054C-4A76-B187-887F2BF9542D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49886531-59468A00-054C-4A76-B187-887F2BF9542D
A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer.
P2860
Q49886531-59468A00-054C-4A76-B187-887F2BF9542D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49886531-59468A00-054C-4A76-B187-887F2BF9542D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4b850770c6e3f33f6d82b63565c77f25b246270a
P2860
PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer.